Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aracea Therapeutics
Medford, Massachusetts, United Statesbiopharmguy.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Aracea Therapeutics develops novel therapeutics aimed at slowing or halting the progression of type 2 diabetes and other related metabolic disorders. No published clinical trial results as of now.
- Therapeutic areas
- Metabolic DisordersEndocrinology
- Modalities
- Likely small molecules or biologics targeting metabolic diseases
- Industry
- Biotech
02
Partnerships
Member of C2I Accelerator/Life Science Incubator, indicating possible collaborations with local biotech ecosystem partners
Beyond the preview
Go deeper on Aracea Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aracea Therapeutics.